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doi:10.1016/j.kjms.2010.12.015Abstract Nandrolone, an anabolic-androgenic steroid, is widely misused by athletes who wish
to rapidly increase muscle mass and performance. An increasing number of reports have indi-
cated that nandrolone may affect and modulate the immune system. This study aimed to inves-
tigate the effects of nandrolone on septic shock-caused immune responses and the cellular
mechanism of action using a sepsis murine model. Before septic shock induction, BALB/c mice
were given a high dose of nandrolone or peanut oil only. After septic shock induction, mice were
sacrificed at different time points. Their blood and tissue specimens were analyzed. It was found
that the high-dose nandrolone group had significantly increased mortality compared with the
control group (p< 0.001). The serum malondialdehyde level was significantly increased in the
high-dose group compared with the control group. Animals administered a high dose of nandro-
lone had significantly increased hepatic tumor necrosis factor-a or splenic interferon-g at 0 and 6
hours. In lung tissue, insulin-like growth factor-1, insulin-like growth factor binding proteins
(IGFBPs) and insulin-like growth factor-1 receptor, and IGFBP1 and IGFBP2mRNAexpressionwere
increased in the high-dose nandrolone group at 6 hours. Nandrolone abusemay hasten the death
of patients with septic shock and may aggravate septic shock in mice.sive Breast Cancer Center, Changhua Christian Hospital, 135 Nanhsiao St, Changhua 500, Taiwan.
org.tw (D.-R. Chen).
vier Taiwan LLC. All rights reserved.
Nandrolone aggravates septic shock 223摘要 諾龍（Nandrolone），一種人工合成的同化性類固醇，許多運動員都會用以快速增加肌肉
量及運動表現。越來越多報導指出諾龍可能會影響並調節免疫系統。本研究欲分析諾龍對敗血性
休克所引起的免疫反應之影響，並利用敗血性休克小鼠模式探討相關細胞作用機制。對BALB/c小
鼠誘發敗血性休克前，將實驗動物分成對照組及實驗組，每日分別給予高劑量花生油或諾龍。小
鼠誘發敗血性休克後，在不同時間點犧牲，採集血液及組織樣本進行分析。分析結果發現，實驗
組（高劑量諾龍）小鼠的死亡率明顯高於對照組（p＜0.001）；同樣地，實驗組血清malondialde-
hyde濃度也明顯較高。給予高劑量諾龍後0及6小時，實驗組動物的肝臟腫瘤壞死因子a或脾臟干
擾素g會明顯上升。實驗組接受高劑量諾龍後6小時，其肺臟組織的第一型類胰島素生長因子
（insulin-like growth factor-1）及其受體蛋白、類胰島素生長因子結合蛋白與類胰島素生長因子
結合蛋白1及2之mRNA表現都會增加。本研究結果證實諾龍會使小鼠的敗血性休克程度惡化，由
此推論諾龍的濫用會加速敗血性休克患者的死亡。
Copyright ª 2011, Elsevier Taiwan LLC. All rights reserved.Introduction
Nandrolone is an anabolic-androgenic steroid (AAS) derived
from the male sex hormone testosterone. More than 40
derivatives can be taken orally or by injection. AAS is
widely used by athletes to increase muscle mass. In the
1990s, many reports of AAS abuse among athletes and
bodybuilders appeared [1]. They used a high dose of AAS to
achieve a rapid increase in muscle mass and enhance
athletic performance. However, anabolic steroid abuse is
associated with many adverse effects with regard to the
liver, cardiovascular function, endocrine and reproductive
systems, and the musculoskeletal and central nervous
systems [2e5]. Although AAS is often misused by people
who want to increase muscle mass, it is also a useful
therapeutic agent in treating a wide range of diseases.
Elderly male patients who are on hemodialysis have
improved nutrition after administration of nandrolone
decanoate for more than 6 months. Nandrolone decanoate
seems to be an acceptable treatment for anemia during
dialysis [6]. Many reports on the effect of nandrolone
therapy on HIV-infected patients have indicated a great
increase in fat-free mass, and that nandrolone therapy may
prove to be beneficial in reversing weight or lean tissue loss
in HIV-infected patients and those with other chronic
catabolic diseases [7e10].
However, there have been only a limited number of
reports clarifying the effects of therapeutic levels of AAS on
immune responses [11e14]. The effects of high-dose AAS on
immunomodulation are unclear. Hughes et al. [2] used
a murine model to mimic anabolic steroids abuse in humans
and demonstrated that a high dose of anabolic steroids can
affect immune responses. Nandrolone decanoate not only
significantly affects cytokine production in human and
murine cells but also inhibits the production of cortico-
tropin in human peripheral blood lymphocytes. Some of
those who abuse anabolic steroids suffer septic shock;
however, whether nandrolone aggravates septic shock
remains an open question. Despite many years of efforts in
attempting to decrease the septic shock mortality rate, the
results are generally disappointing [15e17].
Regarding to the cellular mechanism of nandrolone-
induced muscle fiber hypertrophy and septic shock, Lewis
et al. [18] demonstrated that nandrolone-induced dia-
phragm muscle fiber hypertrophy is mediated by theinfluence of the insulin-like growth factor (IGF) family
within the muscle, and coordinated changes in IGF binding
proteins (IGFBPs) associated with an anabolic response
[19e25]. In addition, Qiao et al. [19] reported that IGF-1
increases extracellular signal-regulated kinases 1/2 (ERK1/
2) activation, a septic shock pathway. Liu et al. [20] pointed
out that IGF-1 activates both phosphoinositide-3 kinase and
ERKs, which contribute to the stimulation of nuclear factor
kappa B (NF-kB)-dependent transcription, also a septic
shock pathway. Furthermore, the NF-kB-responsive gene
products are known to be free radicals, tumor necrosis
factor-a (TNF-a), interferon-g (IFN-g), and IGFBPs. Lewis
et al. [18] reported that the precise actions of IGFBPs
expressed at the different tissue level are unknown and
IGFBPs may exert effects independent of the IGF system.
Nandrolone could have some effects on septic shock by
activating these pathways in the liver, spleen, and lung
through IGFBPs. Hughes et al. [2] also reported that nan-
drolone induced the production of TNF-a from human
peripheral blood lymphocytes and inhibited IFN-g. They
mentioned nandrolone abuser had deleterious effects of
liver neoplasia, hepatic angiosarcoma, and hepatitis. It
remains an open question whether IGF-1 and IGFBPs play
a role on the septic shock pathways, TNF-a, and IFN-g.
In this study, we used an animal model to mimic nan-
drolone abuse and to determinate the effects on immune
responses after septic shock induction. We hypothesized
that high-dose nandrolone increases IGF-Type 1 receptor
(IGF-1R) expression, subsequently modulating innate immu-
nity NF-kB-responsive gene transcription and increasing free
radical, TNF-a, IFN-g, and IGFBPs production.
Material and methods
Animals
Male BALB/c inbred mice were purchased from the National
Laboratory Animal Breeding and Research Center (Taipei,
Taiwan) and housed individually in the Laboratory Animal
Center, Changhua Christian Hospital (Changhua, Taiwan)
with food and water available ad libitum. They were kept
on a 12:12 hour light/dark cycle. All studies were initiated
with male BALB/c mice that were approximately 6 weeks of
age. All surgical procedures and care administered to the
224 C. Lin et al.animals in this study were approved by the Laboratory
Animal Care and Use Committee of Changhua Christian
Hospital, Changhua, Taiwan.
Induction of septic shock
Septic shock is defined as a serious medical condition
caused by decreased tissue perfusion and oxygen delivery
as a result of infection and sepsis; the immune systems of
septic shock patients cannot deal with infection as effec-
tively as those of healthy adults [17]. For this study,
Escherichia coli ATCC25922 (ATCC, Rockville, MD, USA) was
cultured in Luria-Bertani broth (LB, Difco, Detroit, MI, USA)
at 37C and harvested at the mid-log phase for inoculation.
The concentration of bacteria was determined with
a spectrophotometer with an optical density (600 nm) of 1
equal to 108 colony forming unit (CFU)/mL. Mice were
inoculated intraperitoneally with 7 108 CFU of E coli in
sterile saline to induce septic shock. The inoculums were
plated on nutrient agar plates and incubated at 37C for 24
hours to determined viable counts.
Nandrolone administration
Nandrolone-phenylpropionate (nandrolone; China Chemical
& Pharmaceutical Co. Ltd., Taipei, Taiwan) was dissolved in
peanut oil. In a survival assay, 24 BALB/c mice were sepa-
rated into three groups. Group one (nZ 8) received low-
dose nandrolone (0.025 mg/mouse), group two (nZ 8)
received high-dose nandrolone (0.25 mg/mouse), and group
three (nZ 8) received peanut oil only (5 mL/kg) by intra-
peritoneal injection, respectively, once a day for 14
consecutive days before infection with bacterial inocula-
tion. The doses of nandrolone were estimated according to
a previous study [18], and the high-dose group was defined
as the nandrolone abuse group in this study.
For the assay of the effect of nandrolone abuse on
pathophysiological features, 24 BALB/cmice were randomly
separated into two groups. One group (nZ 12) was injected
intraperitoneally with high-dose nandrolone (0.25 mg/
mouse/d), and the other group (nZ 12) received isovolemicTable 1 Primers used to detect real-time polymerase chain rea
Genes Primer seque
mouse b-actin 50-TTGTGATGGACTC
50-TCATCACTATTGGC
mouse IGF-I 50-GGTTTATGAATGGTT
50-GCCACTTGACTACTT
mouse IGF-1R 50-CAAGCT GTGTGTC
50-TGATTCGGTTCTT
mouse IGFBP1 50-GCCGACCTCAAGA
50-GTAGACACACCAG
mouse IGFBP2 50-CCCGAGTGCCATC
50-GCTCAGTGTTGGT
mouse IGFBP3 50-GACACCCAGAACT
50-CATACTTGTCCACA
bpZ base pairs; IGF-1RZ insulin-like growth factor type 1 receptor;peanut oil by intraperitoneal injection for 14 days. On the
14th day, 1 hour after the completion of treatment, all mice
were inoculated with E coli (7 108 CFU/mouse) by intra-
peritoneal injection and were sacrificed at 0, 3, or 6 hours
after E coli challenge.
Determination of numbers of viable bacteria
Mice were sacrificed by inhalation of ether; and the
abdominal cavity, blood, liver, spleen, and lung were
obtained aseptically. The organs were homogenized with
a cell strainer (BD Falcon, Bedford, MA, US) in sterile
saline. The abdominal cavities, portions of blood, and organ
homogenates were placed on nutrient agar plates and
cultured at 37C for 24 hours to determine the E coli
burden. The remaining blood was collected in heparinized
tubes, centrifuged at 1,500 revolutions per minute (rpm)
for 10 minutes at 4C to obtain the plasma, and then stored
at 80C until use.
Determination of cytokines in organ homogenates
The remaining organ homogenates were centrifuged at
3,000 rpm for 15 minutes at 4C, and the supernatants were
collected and stored at 80C until assay. The TNF-a level
in supernatants of liver homogenate and the IFN-g level in
supernatants of spleen homogenate were measured with
a commercial enzyme-linked immunosorbent assay kit
(Biosource, Camarillo, CA, USA).
Determination of the malonaldehyde concentration
in serum
Lipid peroxidation parameter malonaldehyde (MDA) is
a well-known index of free radical activity. For the
measurement of MDA, we used thiobarbituric acid, which
measures MDA-reactive products. Whole blood samples
were collected in serum separator tubes, allowed to clot
for 30 minutes, centrifuged at 2,000 rpm for 15 minutes at
room temperature, and stored at 80C until assayed.
Then, 0.5 mL serum and 2.5 mL trichloroacetic acid werection
nces Amplicon size (bp)
CGGAGAC-30
AACGAGC-30
309
CCCTTATCT-30
ATTTGCTAT-30
167
TCCGAAA-30
CCAGGTC-30
161
AATGGAA-30
CAGAGT-30
198
TCTTCTA-30
CTCTTTC-30
200
TCTCCTC-30
CACCAGC-30
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Figure 1. Survival curve, the effect of nandrolone on
subsequent septic shock. Mice were divided into three groups:
the control group was given peanut oil only; the low-dose and
high-dose nandrolone groups were given 0.025 mg/mouse and
0.25 mg/mouse, respectively for 14 days. A significant differ-
ence (pZ 0.001) in survival was observed in the high-dose
nandrolone-treated mice (0.25 mg/mouse, intraperitoneally
[i.p.], nZ 8) compared with the control mice (peanut oil,
0.1 mL/mouse, i.p., nZ 8). No significant decrease (p> 0.05)
in survival was observed in the low-dose nandrolone-treated
mice (0.025 mg/mouse, i.p., nZ 8) compared with the control
mice.
Nandrolone aggravates septic shock 225mixed and centrifuged at 3,300 rpm for 10 minutes. The
pellet was collected, rinsed with 2.5 mL 10% acetic acid,
and resuspended in 2.5 mL 10% acetic acid. After adding
0.2% thiobarbituric acid (in 2 mol/L Na2SO4), the mixture
was mixed, heated at 100C for 30 minutes, and transferred
onto ice immediately. MDA was then extracted with 2 mL n-
Butanol. The upper layer was collected and the absorption
was measured at 531 and 560 nm. A Model UV-240 (Shi-
mazu, Kyoto, Japan) double-beam UV visible recording
spectrophotometer, equipped with the Model OP 1-2 option
program, was used for zero-order and second-derivative
measurements. Scans were obtained with a 2-nm band-
width, a scan speed of 180 nm/min, and an absorbance
scale of 0.02e0.2 nm (full scale). The second-derivative
spectrum of MDA was measured from 500 to 600 nm in
a 1-cm (1 mL) quartz cuvette against a freshly prepared
reagent blank. Each sample was measured four times to
ensure the precision of measurement. The peak amplitude
at 531 and 560 nm with respect to the adjacent satellite
peak (at a longer wavelength) was measured. A standard
curve was prepared by treating standards in the same
manner, and sample concentrations were calculated
according to this curve. The difference in absorbance
between 531 and 560 nm was measured; the MDA concen-
tration was calculated from a calibration curve of serial
standards and corrected by multiplying the dilution factor
(the final volume of the aqueous layer).
Real-time polymerase chain reaction
Reverse transcription was performed using a kit for cDNA
synthesis (Takara, Kyoto, Japan). Reactions were run on
a LightCycler 3.0 (Roche, Penzberg, Germany). Thermal
cycling conditions consisted of initial steps of 15 seconds at
95C, followed by 72C for 30 seconds, for a total of 40
cycles. All data were normalized to b-actin mRNA levels to
account for any variation in RNA concentrations between
samples.
The expressions of IGF-1R and IGFBPs in the lungs were
quantitatively examined by real-time polymerase chain
reaction (PCR) with the TaqMan-probed real-time PCR assay
(Roche Diagnostic, Germany). The mouse b-actin was used
as an endogenous control gene. The primer pairs used for
IGF-1R and IGFBPs gene transcripts are shown in Table 1.
The amplification of the target genes was as follows: 95C
for 10 minutes, followed by 50 cycles of 95C for 15
seconds, and 60C for 1 minute. Each sample was calcu-
lated in three different experiments.
Statistical analysis
The effects of intervention were first tested by directly
comparing the nandrolone and control groups. Data in the
tables, figures, and text were expressed as mean
standard deviation. The difference between groups was
determined using a two-tailed unpaired Student t test (for
means of continuous variables), as indicated. A p value of
less than 0.05 was considered statistically significant, based
on a 0.9 power. Statistical analyses were performed using
SPSS software (SPSS version 10.0; SPSS Inc., Chicago, IL,
USA).Results
To explain whether nandrolone abuse is associated with
mortality in the user who suffers septic shock, we defined
the high-dose nandrolone group as the nandrolone abuse
group. Animals administered high-dose nandrolone had
significantly increased mortality compared with the control
group (Fig. 1, p< 0.001), but there was no effect on the
survival rate of the low-dose nandrolone group and the
control group. These data indicate the dose of nandrolone
was associated with mortality, especially during septic
shock. Use of high-dose nandrolone may hasten mortality
because of septic shock.
The bacterial burden may be linked to increased
mortality in high-dose nandrolone-treated mice during
septic shock. We examined the bacterial load in the
abdominal cavity fluid, whole blood, liver, and spleen and
found no significant difference between the high-dose mice
and the control mice (Fig. 2). However, many pathophysi-
ological changes were observed during severe sepsis and
septic shock, and one of the most striking was metabolic
derangement. Hyperglycemia was the most important of
the metabolic changes [26,27]. We measured the glucose
level in the blood at 0, 3, and 6 hours after E coli inocu-
lation. The blood glucose in the high-dose nandrolone
group showed no significant difference compared with the
control group at 0 and 6 hours (Fig. 3A). These data indicate
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Figure 2. Effect of high-dose nandrolone on the bacterial burden. The effect of high-dose nandrolone (0.25 mg/mouse/d,
intraperitoneally [i.p.], for 14 days) on the bacterial burden of the (A) abdominal cavity; (B) whole blood; (C) liver; and (D) spleen
of mice inoculated with Escherichia coli ATCC 25922. The bacterial burden count in the abdominal cavity, whole blood, liver, and
spleen is shown as CFU/mL, mean standard deviation. No significant increase (p> 0.05) in the bacterial burden was observed in
the abdominal cavity fluid, and in the whole blood, liver, and spleen of high-dose nandrolone-treated mice compared with the
control mice. CFUZ colony forming units.
226 C. Lin et al.that the increased mortality with use of high-dose nan-
drolone during septic shock was not significantly related to
the bacterial load or metabolic change. The effect of
nandrolone on mortality may manifest through other
pathways.
MDA is an end product produced from the peroxidation
of cell membrane lipid, and lipid peroxidation is triggered
by a variety of proinflammatory mediators [28,29]. Serum
MDA levels were assessed as markers of lipid peroxidation
and hence oxidative stress. We measured the serum MDA
levels at 0, 3, and 6 hours after septic shock induction. Mice
receiving high-dose nandrolone had significantly increased
MDA levels in serum compared with the control group,
which was given peanut oil only (Fig. 3B). In addition, we
determined the proinflammatory cytokine production;
hepatic TNF-a and splenic IFN-g were significantly
increased at 0 and 6 hours (Fig. 3C and D). These data
indicated use of high-dose nandrolone influences immuno-
modulation during septic shock by increasing proin-
flammatory cytokine production and enhancing peroxidant
production by lipid peroxidation.To determine whether IGF-1R is the mediator involved in
the modulation of high-dose nandrolone in sepsis, we
measured the expression of lung IGF-1R and IGFBPs mRNAs
using real-time reverse transcription-PCR. Compared with
0 hour, we demonstrated that high-dose nandrolone
increased lung IGF-1R, as well as IGFBPs mRNA expression,
at 6 hours (Fig. 4). Neither increase of IGFBP2 expression
nor decrease of IGFBP3 expression were found (p> 0.05).
These data indicated that high-dose nandrolone influences
IGF-1R and IGFBPs in septic shock.Discussion
To our knowledge, this is the first report on high-dose nan-
drolone, an AAS that aggravates septic shock in a murine
model. This study shows that high-dose nandrolone increases
serum-free radical parameter MDA production, hepatic
TNF-a, splenic IFN-g, and lung IGF-1R, as well as IGFBPs
mRNA expression, which may modulate the pathogenesis of
septic shock.
Figure 3. Effect of high-dose nandrolone on blood, liver, and spleen. The effect of high-dose nandrolone (0.25 mg/mouse/d,
intraperitoneally [i.p.], for 14 days) on (A) glucose in the blood; (B) MDA in the blood; (C) TNF-a of the liver; and (D) IFN-g of the
spleen in mice inoculated with Escherichia coli ATCC 25922. The data are shown as mean standard deviation. No significant
decrease (p> 0.05) of glucose was observed at 0 and 6 hours in the blood of the high-dose nandrolone-treated mice compared with
the control mice. High-dose nandrolone increased serum MDA levels at 0, 3, and 6 hours. High-dose nandrolone significantly
increased liver TNF-a levels at 0 and 6 hours (C) and spleen IFN-g levels at 0 and 6 hours (D). IFN-gZ interferon-g; MDAZma-
lonaldehyde; TNF-aZ tumor necrosis factor-a.
Nandrolone aggravates septic shock 227Our data demonstrated that many of the variable base-
lines differed in the high-dose nandrolone-treated and
control mice at 0 hour. This implies that high-dose nan-
drolone, and not septic shock, is related to the baselines. In
addition, our results are consistent with those of a previous
study [18] that reported that there was a significant
increase in metabolic imbalance after nandrolone therapy.
Nandrolone abuse results in a hormonal and metabolic
imbalance that impacts surrogate variables. That is also
why we used male mice in this study to reduce the
menstrual impact on hormonal and metabolic imbalance.
However, we neither have precise statistics on how often
nandrolone abusers die from septic shock nor how long the
effects of AAS persist following cessation. In this study,
there was no cessation for more than 24 hours.
Our data showed that free radical parameter serum MDA
is enhanced by high-dose nandrolone. This is in accordancewith the study by Green et al. [30] that reported that
nandrolone induces changes in the behavior of the nitric
oxide dilator system in the blood flow responses of the
human brachial artery. On the other hand, Ferrer et al. [31]
found that nandrolone inhibited nitric oxide production in
rabbit aorta endothelium.
We confirmed that high-dose nandrolone increases
hepatic TNF-a at 0 and 6 hours. This finding is in accordance
with that of a previous study. Hughes et al. [2] found
that nandrolone directly induces the production of the
inflammatory cytokines TNF-a and interleukin-1 b (IL-1 b)
from human peripheral blood lymphocytes, but has no
effect on IL-2 or IL-10 production. Modulating peripheral
blood lymphocytes, then hepatic TNF-a, sequentially,
might be the pathway through which high-dose nandrolone
modulates the liver response in septic shock. Contrary to
our supposition, our data demonstrated that high-dose
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Figure 4. Effect of high-dose nandrolone on lung IGF-1R and
IGFBPs. The folds were defined as the ratios of the 6-hour real-
time PCR value to 0 hour. High-dose nandrolone induction of
IGF-1R and IGFBP1 mRNA expression in lung tissue in vivo.
BALB/c mice were injected with a vehicle or high-dose
nandrolone (0.25 mg/mouse/d for 14 days) intraperitoneally.
Mice were sacrificed before (0 hour) and 6 hours after
Escherichia coli ATCC25922 administration. The data are shown
as mean standard deviation. *Folds of high-dose nandrolone
were significantly different from control (p< 0.05). IGF-1RZ
insulin-like growth factor type 1 receptor; IGFBPZ insulin-like
growth factor binding proteins; PCRZ polymerase chain
reaction.
228 C. Lin et al.nandrolone increases splenic IFN-g levels at 0 and 6 hours.
Thus, IFN-g may be another pathway that high-dose nan-
drolone uses to modulate the pathogenesis of septic shock.
In contrast, Hughes et al. [2] reported that nandrolone
inhibited IFN production in human WISH and murine L-929
cells. Meanwhile, in this study the blood glucose in the
high-dose nandrolone group showed no significant differ-
ence compared with the control group at 0 and 6 hours
(Fig. 3A). The interaction of TNF-a, IFN-g, and blood
glucose remained unclear in this study. Nandrolone may
cause TNF-a and IFN-g upregulations, which did not mean
this could be the side effect. This phenomenon may reflect
the protection mechanism in the immune system. On the
other hand, immune cells (such as macrophage, dendritic
cell, and lymphocytes) and endothelial cells are known to
play the key roles in the regulation of the pathophysiolog-
ical process of sepsis through the proinflammatory media-
tors (e.g. IL-1, nitric oxide) and anti-inflammatory
mediators (e.g. IL-10) [32]. Further study of the mediators
might be necessary to clarify the cellular mechanism in vivo
and in vitro.
High-dose nandrolone increased lung IGFBP1 and IGFBP2
in this study, but decreased lung IGFBP3; this result
contrasts with that of a previous study, in which nandrolone
was shown to increase IGFBP3 in the diaphragm (Lewis
et al. [18]). However, there are potential limitations to this
study. First, whether or not IGF-1R was induced by high-
dose nandrolone is still questionable. The study also does
not clearly address the tissue-specific differences. The
liver is supposed to be the main source of IGF-1. Further
study is necessary to clarify the problem. Lung ERKs and
NF-kB might provide us with some information regardingmodulation in the lung. Second, this study does not take
into account the fact that the ERKs pathway modulates the
cell cycle. The IGF-1R-ERKs-AP-1-cdk/cyclin-cell prolifera-
tion pathway and other ERKs pathways might contribute to
septic shock pathogenesis [33]. Whether high-dose nan-
drolone influences the cell cycle is unclear.
Most of the IGF-1 in the blood is associated with a 150-kD
complex consisting of IGF-I itself (g subunit), glycosylated
IGF binding protein-3 (IGFBP3, b subunit), and a glycosy-
lated acid-labile protein (a subunit). Reed et al. [34]
reported that a decrease in IGF-1 has been seen in
patients with breast cancer treated with tamoxifen. The
mechanisms by which circulating IGF-1 levels are decreased
reduce hepatic IGF-I synthesis and attenuate growth
hormone action by increasing growth hormone-binding
protein production. However, our results substantiated that
high-dose nandrolone increases lung IGFBP1 as well as
IGFBP2 (Fig. 4) and decreases lung IGFBP3. On the other
hand, all forms of IGFBPs have a high affinity for IGF-1. Each
binding protein has unique features, including post-
translational modifications, tissue distribution, and the
ability to enhance or attenuate IGF-1 actions. Pannier et al.
[35] reported that IGFBP3 mRNA is weakly expressed in
fetal kidney. Although the steady-state level of IGFBP3
mRNA is low, its rate of translation may be high, resulting in
relatively high levels of its IGFBP3 protein that are eligible
for posttranslation modulation. Modulation could occur at
the posttranslational stage for IGFBP3 in the lung.
Nandrolone has been reported to decrease intramus-
cular branched-chain amino acids in trauma patients [36].
Furthermore, enteral hyperalimentation with an elemental
diet (e.g. Vivonex) was reported by Moss et al. [37] to
elevate serum branched-chain amino acid (leucin, isoleu-
cine, and valine) levels.
In this study, we also observed those mice receiving
high-dose nandrolone demonstrated muscle hypertrophy
that might point out the abuse effects. However, we did not
have precise statistics on how strong high-dose nandrolone
induced muscle hypertrophy. It is one of potential limita-
tions of this study.
In conclusion, it is suggested that use of high-dose nan-
drolone may aggravate septic shock and increases the
serum MDA level, hepatic TNF-a, splenic IFN-g, and lung
IGF-1R, as well as lung IGFBPs mRNA expression in mice.
Nandrolone may have the serious potential side effect of
septic shock for its abuser.
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